
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of GridAI Technologies (NASDAQ:GRDX) through any online brokerage.
Other companies in GridAI Technologies’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
There is no analysis for GridAI Technologies to provide a consensus price target.
The stock price for GridAI Technologies (NASDAQ: GRDX) is $4.7 last updated October 16, 2026 at 5:59 PM EDT.
There are no upcoming dividends for GridAI Technologies.
GridAI Technologies does not have any upcoming earnings scheduled.
There is no upcoming split for GridAI Technologies.
GridAI Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
GridAI Technologies Corp, formerly known as Entero Therapeutics Inc, is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address...